Paytm faces major troubles as brokerage firm Jefferies downgrades stock to 'underperform' and cuts price target. The Reserve Bank of India's restrictions on Paytm's lending business, along with concerns over non-compliance, reputation risks, and potential impact on profitability have led to the downgrade. This could potentially bring a 34% downside in the stock's value.

📍Glenmark Pharma joined hands with Pfizer to launch Abrocitinib in India. 📍Shree Cement has recorded 165% on-year growth in standalone net profit at Rs 734 crore for Q3FY24. 📍Thomas Cook (India) registered a 241% y/y growth in consolidated profit at Rs 90.5 crore during Q3FY24. 📍KKR and CPP are likely to sell shares worth around $465 million, or Rs 3,800 crore in Indus Towers.

Asian markets are struggling after Wall Street's late slide, but investors still expect interest rate cuts in the US despite a delay from the Federal Reserve. Fed Chair Jerome Powell indicated a cut could happen as early as May due to weak employment gains and slowing inflation. The delayed cut has also led to bets for more aggressive cuts in the future, causing bond yields to fall.